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Reply
We appreciate the interest of Dr. Isaaz for our work (1). In regard
to our initial analysis, we did not calculate the flow after the
minimal intervention in patients who presented with occluded
vessels, but further to this request this parameter was randomly
(every second) estimated in one-half (225) of these patients;
Thrombolysis In Myocardial Infarction (TIMI) flow grade 1 was
restored in 46.6%, TIMI flow grade 2 in 38.8%, and TIMI flow
grade 3 in 14.6%.
The imbalances in the baseline characteristics among groups
are related to the retrospective nonrandomized nature of our
study. Appropriate multivariable statistical analysis was per-
formed to account for these imbalances. For the same reason,
established parameters related to clinical outcomes were missing
as addressed in the extensive limitations paragraph. The influ-
ence of the baseline characteristics imbalances and missing
parameters on the results of the study remains speculative. For
example, during the review process, we were asked to perform
the analysis excluding the patients presenting with stent throm-
bosis. By doing so, no difference was observed in the resultant
independent predictors including large thrombus burden.
By no means could our results support the hypothesis that
immediate stenting can probably be avoided in many patients at
the acute phase of ST-segment elevation myocardial infarction
(STEMI) once flow has been restored using minimal intervention,
since all of our patients were stented during the index procedure.
Such an approach partly questions the well-established superiority
of bare-metal stents compared with balloon angioplasty (2– 4), and
beyond the questionable efficacy it has logistical and financial
implications that would make it quite unlikely to be explored in a
randomized fashion. In our view, in a STEMI setting, optimization
of all periprocedural parameters, including thrombus management by
pharmacologic and mechanical means, is the appropriate way to
go forward.
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Prophylactic Use of Hemodialysis
to Prevent Radiocontrast-Induced
Nephropathy
The Discussion Is Open Again!
Lee et al. (1) present very interesting results on the prophylactic
use of hemodialysis to prevent radiocontrast-induced nephropathy.
Unfortunately, the quality of their discussion falls behind the
quality of the data presented. The authors somehow fail to
mention that several randomized controlled studies have previously
failed to show an improvement of renal outcome by prophylactic
hemodialysis after radiocontrast media application and that a
recent meta-analysis of the controlled studies has revealed no
advantage of prophylactic hemodialysis with respect to outcome
(2). The failure to mention the previous controlled studies hin-
dered the authors to emphasize the differences between their study
and the ones previously done.
In contrast to previous studies including our own (2,3), the
authors were very careful to avoid intravascular volume depletion
during the prophylactic dialysis procedure. Not only was there no
ultrafiltration provided during dialysis, but saline was administered
at the beginning of the dialysis procedure to counteract expected
volume shifts out of the vascular space into the intracellular space
during dialysis. Although patients might have profited from the
careful volume control during the prophylactic dialysis session, it is
conceivable that the poor outcome of patients without dialysis
might have resulted from the lack of a comparable volume
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management. According to protocol, patients were dialyzed when
they remained oliguric despite 1,000 mg of furosemide. In a setting
where dialysis is possible at any time, the approach to oliguria
might be the application of volume rather than furosemide!
No study has so far been done in patients with such an advanced
degree of renal failure (i.e., with a mean creatinine clearance of
about 13  4 ml/min), and the observed poor outcome of the
patients in the control group might well be related to the advanced
renal failure before the procedure. However, polymorbid patients
with a glomerular filtration rate slightly above 10 ml/min might
profit from the initiation of a chronic renal replacement therapy
even without the administration or radiocontrast media.
Given all the information available today, the study by Lee et al.
(1) does not provide enough evidence to prophylactically dialyze all
patients with advanced renal failure; nevertheless, it certainly
reopens the discussion about this subject!
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Reply
Many previous studies have shown renal failure is the main risk factor
predicting development of contrast nephropathy. Renal failure im-
pairs excretion of contrast medium, prolongs exposure to contrast
medium, and enhances its damage. According to the pharmacokinetic
characteristics of contrast medium, it can be efficiently removed from
plasma by hemodialysis, even better than by a normal kidney (1).
Theoretically, reduction of exposure of contrast medium by hemodi-
alysis should prevent contrast nephropathy. Although detailed com-
parison between our experiment and previous studies had not been
mentioned in our report (2), I would like to re-emphasize the key
factor resulting in a beneficial impact of preventive dialysis in contrast
nephropathy is selection of high-risk patients. Most previous studies
with a negative result either included a small number of patients or
were not properly randomized (3,4).
It is generally accepted that renal replacement therapy should be
started when glomerular filtration rate is 15 ml/min with uremic
symptoms or evidence of malnutrition. However, until now, no strict
randomized controlled trial has proven that early initiation of dialysis
accounts for a better survival. Despite the availability of clinical
guidelines for the timing of dialysis initiation, most patients started
the treatment at very low levels of glomerular filtration rate. There-
fore, in addition to an uneventful post-catheterization course, shorter
duration of hospitalization, and lower costs, preventive hemodialysis
can prevent early entrance of an unexpected dialysis-dependent
condition. According to our preliminary results of post-hospitalization
follow-up, the benefit can be maintained for as long as 1 year after
contrast exposure, showing a more than 2-fold 1-year cumulative
dialysis-free survival (85% vs. 40%, p  0.001). Furthermore, patients
with moderate renal failure might benefit from the strategy as well as
those with advanced renal failure. In this patient population, it is more
difficult to appreciate its impact in short-term investigation. To justify
use of preventive hemodialysis in these patients, future investigation
should look into the impact of the strategy applied in diabetes patients
with moderate renal failure and focus on the incidence of plasma
creatinine level doubling after contrast medium exposure.
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